Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified vero cell vaccine produced in china.
We evaluated the immunogenicity, safety, and antibody persistence of a Vero cell rabies vaccine manufactured in China, compared with those of Verorab. Adequate titers of antibody were observed for the two vaccines. ChengDa rabies vaccine could be a promising alternative vaccine for many developing countries which cannot afford expensive rabies vaccines.
Wang
Chuanlin
C
Emergency Department, Peking University People's Hospital, Beijing 100044, People's Republic of China. ERwangchuanlin@gmail.com.
Zhang
Xiaowei
X
Song
Qingkun
Q
Tang
Kun
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D002648:Child; D002681:China; D002522:Chlorocebus aethiops; D003906:Developing Countries; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011818:Rabies / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000009:adverse effects / Q000235:genetics* / Q000276:immunology*; D022223:Vaccines, Subunit / Q000009:adverse effects / Q000235:genetics / Q000276:immunology; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000235:genetics / Q000276:immunology; D014709:Vero Cells; D055815:Young Adult
D000914:Antibodies, Viral; D011819:Rabies Vaccines; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic